TY - JOUR
T1 - Roadmap on magnetic nanoparticles in nanomedicine
AU - Wu, Kai
AU - Wang, Jian-Ping
AU - Natekar, Niranjan A
AU - Ciannella, Stefano
AU - González-Fernández, Cristina
AU - Gomez-Pastora, Jenifer
AU - Bao, Yuping
AU - Liu, Jinming
AU - Liang, Shuang
AU - Wu, Xian
AU - Nguyen T Tran, Linh
AU - Mercedes Paz González, Karla
AU - Choe, Hyeon
AU - Strayer, Jacob
AU - Iyer, Poornima Ramesh
AU - Chalmers, Jeffrey
AU - Chugh, Vinit Kumar
AU - Rezaei, Bahareh
AU - Mostufa, Shahriar
AU - Tay, Zhi Wei
AU - Saayujya, Chinmoy
AU - Huynh, Quincy
AU - Bryan, Jacob
AU - Kuo, Renesmee
AU - Yu, Elaine
AU - Chandrasekharan, Prashant
AU - Fellows, Benjamin
AU - Conolly, Steven
AU - Hadimani, Ravi L
AU - El-Gendy, Ahmed A
AU - Saha, Renata
AU - Broomhall, Thomas J
AU - Wright, Abigail L
AU - Rotherham, Michael
AU - El Haj, Alicia J
AU - Wang, Zhiyi
AU - Liang, Jiarong
AU - Abad-Díaz-de-Cerio, Ana
AU - Gandarias, Lucía
AU - Gubieda, Alicia G
AU - García-Prieto, Ana
AU - Fdez-Gubieda, Mª Luisa
PY - 2024/11/5
Y1 - 2024/11/5
N2 - Magnetic nanoparticles (MNPs) represent a class of small particles typically with diameters ranging from 1 to 100 nanometers. These nanoparticles are composed of magnetic materials such as iron, cobalt, nickel, or their alloys. The nanoscale size of MNPs gives them unique physicochemical (physical and chemical) properties not found in their bulk counterparts. Their versatile nature and unique magnetic behavior make them valuable in a wide range of scientific, medical, and technological fields. Over the past decade, there has been a significant surge in MNP-based applications spanning biomedical uses, environmental remediation, data storage, energy storage, and catalysis. Given their magnetic nature and small size, MNPs can be manipulated and guided using external magnetic fields. This characteristic is harnessed in biomedical applications, where these nanoparticles can be directed to specific targets in the body for imaging, drug delivery, or hyperthermia treatment. Herein, this roadmap offers an overview of the current status, challenges, and advancements in various facets of MNPs. It covers magnetic properties, synthesis, functionalization, characterization, and biomedical applications such as sample enrichment, bioassays, imaging, hyperthermia, neuromodulation, tissue engineering, and drug/gene delivery. However, as MNPs are increasingly explored for in vivo applications, concerns have emerged regarding their cytotoxicity, cellular uptake, and degradation, prompting attention from both researchers and clinicians. This roadmap aims to provide a comprehensive perspective on the evolving landscape of MNP research.
AB - Magnetic nanoparticles (MNPs) represent a class of small particles typically with diameters ranging from 1 to 100 nanometers. These nanoparticles are composed of magnetic materials such as iron, cobalt, nickel, or their alloys. The nanoscale size of MNPs gives them unique physicochemical (physical and chemical) properties not found in their bulk counterparts. Their versatile nature and unique magnetic behavior make them valuable in a wide range of scientific, medical, and technological fields. Over the past decade, there has been a significant surge in MNP-based applications spanning biomedical uses, environmental remediation, data storage, energy storage, and catalysis. Given their magnetic nature and small size, MNPs can be manipulated and guided using external magnetic fields. This characteristic is harnessed in biomedical applications, where these nanoparticles can be directed to specific targets in the body for imaging, drug delivery, or hyperthermia treatment. Herein, this roadmap offers an overview of the current status, challenges, and advancements in various facets of MNPs. It covers magnetic properties, synthesis, functionalization, characterization, and biomedical applications such as sample enrichment, bioassays, imaging, hyperthermia, neuromodulation, tissue engineering, and drug/gene delivery. However, as MNPs are increasingly explored for in vivo applications, concerns have emerged regarding their cytotoxicity, cellular uptake, and degradation, prompting attention from both researchers and clinicians. This roadmap aims to provide a comprehensive perspective on the evolving landscape of MNP research.
KW - hyperthermia
KW - magnetic biosensing
KW - magnetic imaging
KW - biomedical application
KW - tissue engineering
KW - drug delivery
KW - magnetic nanoparticle
U2 - 10.1088/1361-6528/ad8626
DO - 10.1088/1361-6528/ad8626
M3 - Review article
SN - 0957-4484
VL - 36
JO - Nanotechnology
JF - Nanotechnology
IS - 4
M1 - 042003
ER -